Skip to main content
. 2022 Feb 28;44(1):368–380. doi: 10.1080/0886022X.2022.2039195

Figure 2.

Figure 2.

Inhibition of p53 attenuated renal histological and functional damage after cisplatin treatment. (A) HE, PAS, and E-cadherin immunohistochemical staining for the analysis of renal injury in the kidney; (B) tubular damage score for HE staining; (C) tubular damage score for PAS staining; (D) quantification of E-cadherin; (E and F) Cr and BUN levels. Data were expressed as mean ± SD (n = 6); *p < 0.05 versus control, #p < 0.05 versus cisplatin.